Systemic Immune Inflammation-Index and CANLPH Score in Patients with Mitral Stenosis Undergoing Balloon Valvuloplasty

Abstract views: 222 / PDF downloads: 171




CANLPH score, mitral stenosis, percutaneous balloon valvuloplasty, systemic immune-inflammation index


Objective: to evaluate CANLPH score and systemic immune inflammation index (SII) in patients with symptomatic rheumatic mitral stenosis (MS) undergoing percutaneous mitral balloon valvuloplasty (PMBV).

Methods: 62 patients who underwent PMBV in our clinic between 2018 and 2021 were included retrospectively. The patients were divided into 2 groups according to echo score. The CANLPH score was calculated from the cut-off values of C-reactive protein to albumin ratio (CAR), neutrophil to lymphocyte ratio (NLR) and platelet to hemoglobin ratio (PHR), determined with the Youden index and SII by the formula platelet x neutrophil/lymphocyte. P <0.05 was considered statistically significant.

Results: The mean age of the patients was 44.5±10.4 years (40 female, 64.5%). The mean values of SII and CANLPH scores were higher in the Echo score >8 group (p <0.001, both). The mean mitral gradient before and after PMBV was 12.6±5.7mm Hg and 5.0±2.4 mm Hg, and the mean valve area was 1.12±0.27 cm2 and 1.85±0.29 cm2. A statistically significant and negative correlation was observed between the gradient decrease after the procedure and the CANLPH score and SII (r=-0.426, p=0.001 and r=-0.418, p=0.001, respectively). In receiver operating characteristic (ROC) curve analysis, it was concluded that the ability of CANPLH score to predict the higher Echo scores was noninferior to SII with an area under curve (AUC:0.820 (0.701-0.906) and AUC:0.786 (0.664-0.880), z statistics 0.576 and p=0.564.

Conclusion: SII and CANLPH scores are correlated with Echo score. A significant negative relationship was found with both biomarkers and gradient decrease after the PMBV.


Metrics Loading ...


Chandrashekhar Y, Westaby S, Narula J. Mitral stenosis. Lancet 2009; 374: 1271-83.

Selzer A, Cohn KE. Natural History of Mitral Stenosis: A Review. Circulation. 1972:878-89.

Hennessy T, Galvin J, McKenna C, McCann HA, Sugrue DD. Initial experience with percutaneous balloon mitral commissurotomy. Ir Med J 1995;88:100-1.

Silva VR, Neves EGA, Passos LSA, et al. Decreased Cytokine Plasma Levels and Changes in T-Cell Activation Are Associated With Hemodynamic Improvement and Clinical Outcomes After Percutaneous Mitral Commissurotomy in Patients With Rheumatic Mitral Stenosis. Front Cardiovasc Med 2021;7:604826. doi:10.3389/fcvm.2020.604826. eCollection 2020.

Baysal E, Burak C, Cay S, et al. The neutrophil to lymphocyte ratio is associated with severity of rheumatic mitral valve stenosis. J Blood Med 2015;6:151-6. doi: 10.2147/JBM.S82423. eCollection 2015

Tanacan E, Dincer D, Erdogan FG, Gurler A. A cutoff value for the Systemic Immune-Inflammation Index in determining activity of Behcet disease. Clin Exp Dermatol 2021;46:286-91. doi: 10.1111/ced.14432. Epub 2020 Oct 10.

Zuo H, Xie X, Peng J, Wang L, Zhu R. Predictive Value of Novel Inflammation-Based Biomarkers for Pulmonary Hypertension in the Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Anal Cell Pathol (Amst) 2019:5189165. doi: 10.1155/2019/5189165. eCollection 2019.

Bugdayci Basal F, Karacin C, Bilgetekin I, Oksuzoglu OB. Can Systemic Immune-Inflammation Index Create a New Perspective for the IMDC Scoring System in Patients with Metastatic Renal Cell Carcinoma?. Urol Int 2021:1-8. doi: 10.1159/000513456. Online ahead of print.

Komura K, Hashimoto T, Tsujino T, et al. The CANLPH Score, an Integrative Model of Systemic Inflammation and Nutrition Status (SINS), Predicts Clinical Outcomes After Surgery in Renal Cell Carcinoma: Data From a Multicenter Cohort in Japan.Ann Surg Oncol 2019;26:2994-3004.doi: 10.1245/s10434-019-07530-5.Epub 2019 Jun 25.

Agus HZ, Kahraman S, Arslan C, et al. Systemic immune-inflammation index predicts mortality in infective endocarditis. J Saudi Heart Assoc 2020;32:58-64. doi: 10.37616/2212-504

Tosu AR, Kalyoncuoglu M, Biter HI, et al. Prognostic Value of Systemic Immune-Inflammation Index for Major Adverse Cardiac Events and Mortality in Severe Aortic Stenosis Patients after TAVI. Medicina (Kaunas). 2021 Jun 8;57(6):588. doi: 10.3390/medicina57060588.

Esenboğa K, Kurtul A, Yamantürk YY, Tan TS, Tutar DE. Systemic immune-inflammation index predicts no-reflow phenomenon after primary percutaneous coronary intervention. Acta Cardiol 2021 Feb 22:1-8. doi: 10.1080/00015385.2021.1884786. Online ahead of print.

Abacioglu OO, Yildirim A, Koyunsever NY, Ucak HA, Abacioglu S. Relationship between CANLPH score and in-hospital mortality in patients undergoing coronary artery bypass grafting. Biomark Med. 2021 Dec;15(17):1659-1667. doi: 10.2217/bmm-2021-0221.3.1010. eCollection 2020.

Baumgartner H, Hung J, Bermejo J, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr 2009;22:1-23; quiz 101-2. doi: 10.1016/j.echo.2008.11.029.

Peixoto EC, Peixoto RT, Borges IP, et al. Influence of the echocardiographic score and not of the previous surgical mitral commissurotomy on the outcome of percutaneous mitral balloon valvuloplasty. Arq Bras Cardiol 2001;76:473-82.

Palacios IF. Percutaneous mitral balloon valvuloplasty - state of the art. Mini-invasive Surg 2020;4:73.

Krishnamoorthy KM, Dash PK. Prediction of atrial fibrillation in patients with severe mitral stenosis--role of atrial contribution to ventricular filling. Scand Cardiovasc J 2003;37:344-8. doi: 10.1080/14017430310015893

Prendergast BD, Shaw TRD, Iung B, Vahanian A, Northridge DB. Contemporary criteria for the selection of patients for percutaneous balloon mitral valvuloplasty. Heart 2002;87:401-4.

Yetkin E, Qehreli S, Ileri M, et al. Comparison of clinical echocardiographic and hemodynamic characteristics of male and female patients who underwent mitral balloon valvuloplasty. Angiology 2001;52:835-9

Ekinci M, Duygu H, Acet H, et al. The efficiency and safety of balloon valvuloplasty in patients with mitral stenosis and a high echo score: mid- and short-term clinical and echocardiographic results. Turk Kardiyol Dern Ars 2009;37:531-7

Mahfouz RA, Dewedar A, Elzayat A, Elawady W. Usefulness of the Global Echo-Doppler Score (GEDS) in selection of patients with mitral stenosis for percutaneous balloon mitral valvuloplasty. Cardiol J 2014;21:152-7.doi: 10.5603/CJ.a2013.0086. Epub 2013 Jun 25

Arat N, Altay H, Korkmaz S, Ilkay E The effect of baseline pulmonary artery pressure on right ventricular functions after mitral balloon valvuloplasty for rheumatic mitral stenosis: a tissue Doppler imaging study Turk Kardiyol Dern Ars 2008;36:223-30.

İnci S, Erol MK, Bakırcı EM, et al. Effect of percutaneous mitral balloon valvuloplasty on right ventricular functions in mitral stenosis: short- and mid-term results. Anatol J Cardiol 2015;15:289-96. doi: 10.5152/akd.2014.5360. Epub 2014 Jun 3.

Akboğa MK, Akyel A, Şahinarslan A, et al. Neutrophil-to-lymphocyte ratio is increased in patients with rheumatic mitral valve stenosis? Anatol J Cardiol. 2015;15:380-4.doi: 10.5152/akd.2014.5399. Epub 2014 Apr 16.




How to Cite

Abacioglu, O. O., Yıldırım, A., Karadeniz, M., Acele, A., Dindas, F., Koyunsever, N. Y., Dogdus, M., & Kurt, İbrahim H. (2023). Systemic Immune Inflammation-Index and CANLPH Score in Patients with Mitral Stenosis Undergoing Balloon Valvuloplasty. European Journal of Therapeutics, 29(1), 10–16.



Original Articles